Canada Menopause Market Size & Outlook, 2022-2030

The menopause market in Canada is expected to reach a projected revenue of US$ 784.8 million by 2030. A compound annual growth rate of 1.8% is expected of Canada menopause market from 2023 to 2030.
Revenue, 2022 (US$M)
$678.6
Forecast, 2030 (US$M)
$784.8
CAGR, 2023 - 2030
1.8%
Report Coverage
Canada

Canada menopause market highlights

  • The Canada menopause market generated a revenue of USD 678.6 million in 2022 and is expected to reach USD 784.8 million by 2030.
  • The Canada market is expected to grow at a CAGR of 1.8% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • OTC pharma products is the most lucrative treatment segment registering the fastest growth during the forecast period.


Menopause market data book summary

Market revenue in 2022USD 678.6 million
Market revenue in 2030USD 784.8 million
Growth rate1.8% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentOTC pharma products
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, Canada accounted for 4.2% of the global menopause market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. menopause market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 7,368.7 million by 2030.

Dietary supplements was the largest segment with a revenue share of 96.05% in 2022. Horizon Databook has segmented the Canada menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


There is an increase in awareness about dietary requirements, leading to a greater demand for them among older women. A study was conducted to assess the availability of Over-the-counter (OTC) Natural Health Products (NHPs) to Canadian women.

Published by BMC Complementary Medicine and Therapies in March 2015, the study reviewed stores in Edmonton city belonging to nine different pharmacy chains. It found that out of 20 products, around 19 had Canada license numbers and were easily available to women.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

Canada menopause market size, by treatment, 2018-2030 (US$M)

Canada Menopause Market Outlook Share, 2022 & 2030 (US$M)

Canada menopause market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more